Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

Altered levels of cerebrospinal fluid (CSF) peptides related to Alzheimer’s disease (AD) are associated with pathologic AD diagnosis, although cognitively normal subjects can also have abnormal levels of these AD biomarkers. To identify novel CSF biomarkers that distinguish pathologically confirmed...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hu, William T., Chen-Plotkin, Alice, Arnold, Steven E., Grossman, Murray, Clark, Christopher M., Shaw, Leslie M., Pickering, Eve, Kuhn, Max, Chen, Yu, McCluskey, Leo, Elman, Lauren, Karlawish, Jason, Hurtig, Howard I., Siderowf, Andrew, Lee, Virginia M.-Y., Soares, Holly, Trojanowski, John Q.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2880811/
https://ncbi.nlm.nih.gov/pubmed/20232070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00401-010-0667-0
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items